Walgreens Boots Alliance Inc
XETRA:W8A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
W
|
Walgreens Boots Alliance Inc
XETRA:W8A
|
US |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
J
|
JPMorgan Chase & Co
DUS:CMC
|
US |
|
M
|
MTR Corp Ltd
SWB:MRI
|
HK |
|
H
|
Hornbach Baumarkt AG
XHAM:HBM
|
DE |
|
Grifols SA
F:OZTA
|
ES |
|
Avolta AG
SIX:AVOL
|
CH |
|
M
|
Merck KGaA
LSE:0O14
|
DE |
|
GAIL (India) Ltd
LSE:GAID
|
IN |
|
R
|
Riber SA
SWB:RI7
|
FR |
|
N
|
Nissan Chemical Corp
F:NSC
|
JP |
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
M
|
Mitsui Fudosan Co Ltd
DUS:MFU
|
JP |
|
Bilibili Inc
NASDAQ:BILI
|
CN |
|
Takashimaya Co Ltd
TSE:8233
|
JP |
|
I
|
Information Services Group Inc
F:ZZG
|
US |
|
S
|
Sun Hung Kai Properties Ltd
F:SHG
|
HK |
|
Li-Cycle Holdings Corp
OTC:LICYF
|
CA |
|
Premia Finance SpA Societa di Mediazione Creditizia
F:81U
|
IT |
Wall St Price Targets
W8A Price Targets Summary
Walgreens Boots Alliance Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is W8A's stock price target?
Not Available
W8A does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Walgreens Boots Alliance Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Walgreens Boots Alliance Inc?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 3 years is -5%.